Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA puts Cell Therapeutics blood cancer drug on hold after death
Reuters
Monday, June 24, 2013 - 11:01am
tags:
FDA, Cell Therapeutics, tosedostat, leukemia
Tenet to Buy Vanguard Health for $1.8 Billion in Cash
Bloomberg
Monday, June 24, 2013 - 10:58am
tags:
TENET, Vanguard Health Systems, M&A
Pfizer Loses Top Court Bid for Shield From Asbestos Suits
Bloomberg
Monday, June 24, 2013 - 10:56am
tags:
Pfizer, Quigley, Supreme Court
Vivus Script Numbers Showing Traction
Seeking Alpha
Monday, June 24, 2013 - 10:54am
tags:
prescription data, Vivus, Qsymia, obesity
Is The Anti-Obesity Space Going To Get Crowded?
Seeking Alpha
Monday, June 24, 2013 - 10:52am
tags:
obesity, Arena Pharmaceuticals, Orexigen, Vivus, beloranib, Zagfen, Contrave, Belviq, Qsymia
Astellas' Xtandi approved in EU for prostate cancer
Pharma Times, UK
Monday, June 24, 2013 - 10:50am
tags:
Astellas, Xtandi, prostate cancer, Europe, Medivation
Drug lawsuit against Genentech could burden customers
San Francisco Examiner, CA
Monday, June 24, 2013 - 10:46am
tags:
Genentech, PDL Biopharma
Novartis tests copy of Amgen's Enbrel in late-stage trial
Reuters
Monday, June 24, 2013 - 10:44am
tags:
Amgen, Enbrel, generics, Sandoz, Novartis, chronic plaque psoriasis
RegeneRx says Phase 2 trial met primary outcome measure
Yahoo/Fly on the Wall
Monday, June 24, 2013 - 10:42am
tags:
RegeneRx, RGN-137, epidermolysis bullosa
Amarin's Naysayers: Much Ado About Nothing
Seeking Alpha
Monday, June 24, 2013 - 10:40am
tags:
Amarin, Vascepa
Zoetis says fully independent following Pfizer exchange offer
Yahoo/Fly on the Wall
Monday, June 24, 2013 - 10:38am
tags:
Pfizer, Zoetis, animal health
Sanofi Chief Says EU Clinical ‘Data Dump’ to Hurt Drugmakers
Bloomberg
Monday, June 24, 2013 - 10:33am
tags:
Sanofi, Europe, Chris Viehbacher, clinical trials
Bayer rival Boehringer seeks wider use of anti-clotting pill
Reuters
Monday, June 24, 2013 - 10:31am
tags:
Bayer, Boehringer Ingelheim, anticoagulants, Pradaxa, deep vein thrombosis, pulmonary embolism
Teva launches generic Viagra in countries across Europe
The Fly on the Wall
Monday, June 24, 2013 - 10:29am
tags:
generics, Viagra, Teva, Europe
New GSK diabetes drug works, but faces tough competition
Reuters
Monday, June 24, 2013 - 10:28am
tags:
GSK, diabetes, albiglutide, GLP-1 agonist, Victoza, Byetta, Bydureon, Novo Nordisk, Bristol-Myers Squibb, AstraZeneca
Justice Department Sues Sage Pharmaceuticals Inc.
PharmPro
Sunday, June 23, 2013 - 11:40am
tags:
Sage Pharmaceuticals
Is Now a Great Time to Buy Abbott Laboratories Stock?
Motley Fool
Sunday, June 23, 2013 - 11:32am
tags:
Abbott Laboratories
The FDA's Cancer Czar Says He Can't Approve New Drugs Fast Enough
Forbes
Sunday, June 23, 2013 - 11:32am
tags:
FDA
Sanofi Announces Positive Phase 3 Results for Investigational New Insulin U300
Yahoo/Market Wired
Sunday, June 23, 2013 - 11:30am
tags:
Sanofi, U300, insulin, type 2 diabetes, diabetes
Sanofi Announces Positive Phase 3 Data for Once-Daily Lixisenatide for Type 2 Diabetes
Yahoo/PR NewsWire
Sunday, June 23, 2013 - 11:28am
tags:
lixisenatide, type 2 diabetes, diabetes, Sanofi

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.